Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clostridium Infections | 9 | 2020 | 52 | 4.270 |
Why?
|
| Carrier State | 4 | 2014 | 39 | 1.410 |
Why?
|
| Cross Infection | 4 | 2020 | 195 | 1.320 |
Why?
|
| Diarrhea | 2 | 2020 | 63 | 1.170 |
Why?
|
| Enterocolitis, Pseudomembranous | 4 | 2014 | 14 | 0.850 |
Why?
|
| Sentinel Surveillance | 2 | 2020 | 20 | 0.810 |
Why?
|
| Bacterial Proteins | 4 | 2014 | 244 | 0.760 |
Why?
|
| Vancomycin | 2 | 2018 | 60 | 0.750 |
Why?
|
| Minisatellite Repeats | 3 | 2019 | 16 | 0.650 |
Why?
|
| Anti-Bacterial Agents | 3 | 2018 | 1026 | 0.620 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 55 | 0.580 |
Why?
|
| Pediatrics | 1 | 2020 | 341 | 0.570 |
Why?
|
| Bacterial Toxins | 2 | 2014 | 50 | 0.510 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 78 | 0.470 |
Why?
|
| Repressor Proteins | 3 | 2014 | 182 | 0.440 |
Why?
|
| Meat Products | 1 | 2012 | 8 | 0.420 |
Why?
|
| Perineum | 1 | 2011 | 11 | 0.400 |
Why?
|
| Anal Canal | 1 | 2011 | 20 | 0.400 |
Why?
|
| Hospitalization | 1 | 2017 | 977 | 0.380 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 209 | 0.380 |
Why?
|
| Pennsylvania | 4 | 2014 | 46 | 0.360 |
Why?
|
| Genotype | 5 | 2018 | 785 | 0.360 |
Why?
|
| Rifampin | 1 | 2009 | 45 | 0.320 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2009 | 98 | 0.310 |
Why?
|
| Feces | 2 | 2020 | 88 | 0.290 |
Why?
|
| Humans | 19 | 2022 | 68549 | 0.290 |
Why?
|
| Sequence Deletion | 1 | 2006 | 89 | 0.280 |
Why?
|
| Disease Outbreaks | 1 | 2006 | 83 | 0.270 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 110 | 0.230 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 481 | 0.200 |
Why?
|
| Health Personnel | 2 | 2022 | 286 | 0.200 |
Why?
|
| DNA, Bacterial | 2 | 2013 | 150 | 0.190 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2020 | 6 | 0.190 |
Why?
|
| Cryptosporidiosis | 1 | 2020 | 7 | 0.190 |
Why?
|
| Cryptosporidium | 1 | 2020 | 9 | 0.190 |
Why?
|
| Sapovirus | 1 | 2020 | 7 | 0.190 |
Why?
|
| Norovirus | 1 | 2020 | 31 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2014 | 220 | 0.180 |
Why?
|
| Hospitals, Veterans | 1 | 2020 | 147 | 0.170 |
Why?
|
| Inpatients | 1 | 2021 | 208 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 492 | 0.170 |
Why?
|
| Bias | 1 | 2020 | 148 | 0.170 |
Why?
|
| Organ Transplantation | 1 | 2020 | 110 | 0.160 |
Why?
|
| Prevalence | 2 | 2014 | 1609 | 0.160 |
Why?
|
| Sputum | 1 | 2018 | 51 | 0.160 |
Why?
|
| Hospitals | 1 | 2021 | 265 | 0.160 |
Why?
|
| Canada | 1 | 2019 | 266 | 0.160 |
Why?
|
| Data Collection | 1 | 2020 | 420 | 0.160 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2018 | 61 | 0.160 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 245 | 0.150 |
Why?
|
| Adolescent | 4 | 2020 | 8904 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 281 | 0.150 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2018 | 103 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2018 | 411 | 0.150 |
Why?
|
| Genotyping Techniques | 2 | 2014 | 19 | 0.150 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2017 | 17 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2018 | 291 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 208 | 0.150 |
Why?
|
| False Positive Reactions | 1 | 2017 | 95 | 0.140 |
Why?
|
| Cluster Analysis | 3 | 2018 | 219 | 0.140 |
Why?
|
| Metronidazole | 2 | 2013 | 28 | 0.140 |
Why?
|
| Molecular Epidemiology | 2 | 2013 | 16 | 0.140 |
Why?
|
| South Carolina | 2 | 2020 | 2752 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 445 | 0.140 |
Why?
|
| Incidence | 1 | 2020 | 1582 | 0.140 |
Why?
|
| Microbiota | 1 | 2017 | 79 | 0.130 |
Why?
|
| Anti-Infective Agents | 2 | 2013 | 166 | 0.120 |
Why?
|
| Infant, Newborn | 1 | 2020 | 2455 | 0.120 |
Why?
|
| Enterotoxins | 1 | 2014 | 40 | 0.120 |
Why?
|
| Antitoxins | 1 | 2013 | 2 | 0.120 |
Why?
|
| Biological Therapy | 1 | 2013 | 8 | 0.120 |
Why?
|
| Bacterial Vaccines | 1 | 2013 | 32 | 0.110 |
Why?
|
| Infant | 1 | 2020 | 2891 | 0.110 |
Why?
|
| Public Health Surveillance | 1 | 2013 | 18 | 0.110 |
Why?
|
| Swine | 2 | 2012 | 672 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2013 | 71 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2020 | 3187 | 0.110 |
Why?
|
| Aminoglycosides | 1 | 2013 | 54 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 90 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 1753 | 0.110 |
Why?
|
| Young Adult | 4 | 2020 | 5710 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2014 | 224 | 0.100 |
Why?
|
| beta-Lactamases | 1 | 2012 | 33 | 0.100 |
Why?
|
| Meat | 1 | 2012 | 34 | 0.100 |
Why?
|
| Quality of Life | 1 | 2020 | 1515 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2013 | 215 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 4843 | 0.100 |
Why?
|
| Bacteriological Techniques | 1 | 2011 | 49 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2020 | 7268 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 511 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1054 | 0.090 |
Why?
|
| Phylogeny | 2 | 2012 | 196 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2012 | 368 | 0.090 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 11 | 0.080 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2009 | 16 | 0.080 |
Why?
|
| Child | 1 | 2020 | 6401 | 0.080 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 65 | 0.080 |
Why?
|
| Male | 4 | 2020 | 37283 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2020 | 7028 | 0.080 |
Why?
|
| Female | 4 | 2020 | 38021 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 772 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1465 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 838 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 2798 | 0.070 |
Why?
|
| Middle Aged | 4 | 2020 | 21119 | 0.070 |
Why?
|
| Time Factors | 1 | 2014 | 4655 | 0.070 |
Why?
|
| Adult | 4 | 2020 | 21379 | 0.070 |
Why?
|
| Aged | 3 | 2020 | 14842 | 0.060 |
Why?
|
| Base Sequence | 1 | 2006 | 1015 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 1082 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1446 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 41 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 20 | 0.050 |
Why?
|
| Animals | 3 | 2014 | 20880 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2020 | 202 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 507 | 0.040 |
Why?
|
| Maryland | 1 | 2018 | 77 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2018 | 21 | 0.040 |
Why?
|
| Medical Records | 1 | 2018 | 121 | 0.040 |
Why?
|
| Stem Cells | 1 | 2018 | 248 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 1195 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2356 | 0.030 |
Why?
|
| Disease Reservoirs | 1 | 2014 | 7 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2012 | 5 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 196 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2012 | 7 | 0.030 |
Why?
|
| Turkeys | 1 | 2012 | 16 | 0.030 |
Why?
|
| Food Microbiology | 1 | 2012 | 24 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 226 | 0.020 |
Why?
|
| Chickens | 1 | 2012 | 232 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 948 | 0.020 |
Why?
|